Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyNicole M. Kuderer, Kerry L. Reynolds, Petros Grivas et al.|The Lancet|2020Cited by 1.8k
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast CancersAshton C. Berger, Carolyn M. Hutter, Anil Korkut et al.|Cancer Cell|2018Cited by 701
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort StudyDonna R. Rivera, Jeremy L. Warner, Solange Peters et al.|Cancer Discovery|2020Cited by 138
The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19Ang Li, Rachel Rosovsky, Nicole M. Kuderer et al.|Journal of Thrombosis and Haemostasis|2021Cited by 30
Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) RegistryAng Li, Rachel Rosovsky, Nicole M. Kuderer et al.|Blood|2020Cited by 8